PODNL1 and central nervous system cancer: Another factor that may determine LGG aggressiveness in low methylation groups of these PODNL1 CpGs could involve the AKT signaling pathway, which we found to be enriched in this group, as previous studies reported the association between phosphorylation of AKT and glioma aggressiveness [58,59,60,61].